logo

Rumi Scientific

Rumi Scientific's mission is to fast-track the early stage of drug discovery using our predictive models of the human brain for therapeutic success. Many neurodevelopmental diseases do not have treatments due to a lack of a-priori knowledge of the underlying biology. Rumi Scientific's technology is able to model these diseases to help enable the discovery of new targets and drugs, de-risking the current failure-prone cumbersome approach.
For inquiries, please contact us at
E-mail: info@rumiscientific.com
 

Kristen Brennand

kb

Kristen Brennand, Ph.D., SAB Member

 

Kristen Brennand, Ph.D. is a faculty member at the Yale School of Medicine, and a former researcher at the Icahn School of Medicine at Mount Sinai in New York, NY. Her research integrates stem cell-based approaches with CRISPR-mediated genomic engineering strategies, in order to study the impact of patient-specific variants across and between the cell types of the brain. The goal of her research is to uncover the convergence and synergy arising from the complex interplay of the many risk variants linked to brain disease. Dr. Brennand’s work is funded by the National Institutes of Health, the New York Stem Cell Foundation, the Brain Research Foundation, and the Brain and Behavior Research Foundation.


I would like to learn about Rumi Scientific’s novel discoveries to treat genetic diseases.